Drug development

GMP Biologics Manufacturing in End-to-End Drug Development

Biologics, Drug development, GMP, Manufacturing

5 Analytical Challenges in Biosimilar Characterization and Comparability

Biologics, Drug development

Poster

Integrated Modeling of Upstream and Downstream Bioprocessing to Improve Biologics Production Efficiency

Biologics, Drug development, Mabion, Manufacturing

The Role of High-Throughput Screening (HTS) in Cell Line Development and Process Optimization

Biologics, Drug development

Co-Development Partnership Models in Biologics Programs

Biologics, Drug development, Mabion, Partnership

Scaling Antibody Production for ADC Programs

Antibody-drug conjugates, Drug development, Manufacturing

Protein Characterization Techniques for Biologics Development

Analytics, Biosimilars, Drug development, Proteins

Upstream Development for High Yield Biologics Production 

Biologics, Drug development, Manufacturing

The New Era of Biosimilar Development: Seizing the Opportunity Under EMA’s Streamlined Guidelines

Biosimilars, Clinical trials, Drug development, EMA, FDA, Mabion, Regulatory